One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Inside This Issue
doi : 10.1016/S1936-8798(21)00530-6
Volume 14, Issue 8, 26 April 2021, Pages A11-A16
Sex-Related Clinical Characteristics and Outcomes of Patients Undergoing Transcatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation
Sang-DonParkMDab?MathiasOrbanMDac?NicoleKaramMDdEdithLubosMDeDanielKalbacherMDeDanielBraunMDaLukasStolzCAND. MEDaMichaelNeussMDfChristianButterMDfFabienPrazMDgMohammadKassarMDgAnielaPetrescuMDhRomanPfisterMDiChristosIliadisMDiMatthiasUnterhuberMDjPhilippLurzMD, PhDjHolgerThieleMDjStephanBaldusMDi…J?rgHausleiterMDac
doi : 10.1016/j.jcin.2020.12.042
Volume 14, Issue 8, 26 April 2021, Pages 819-827
The authors sought to assess sex-based differences in characteristics and outcomes of patients undergoing transcatheter edge-to-edge mitral valve repair (TMVR) for secondary mitral regurgitation (SMR).
MitraClip: The Battle of the Sexes Will Not Take Place?
PatriceGuerinMD, PhD
doi : 10.1016/j.jcin.2021.01.045
Volume 14, Issue 8, 26 April 2021, Pages 828-829
Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC: MITRAL Trial 1-Year Outcomes
MayraGuerreroMDaDee DeeWangMDbMackram F.EleidMDaAmitPursnaniMDcMichaelSalingerMDdHyde M.RussellMDeSusheel K.KodaliMDfIsaacGeorgeMDgVinayak N.BapatMDgGeorge D.DangasMD, PhDhGilbert H.L.TangMD, MSc, MBAiIgnacioInglesisMDjChristopher U.MeduriMDkIgorPalaciosMDjMarkReismanMDlBrian K.WhisenantMDmAnastasiaJermihovn?TatianaKaptzanPhDo…William W.O’NeillMDb
doi : 10.1016/j.jcin.2021.01.052
Volume 14, Issue 8, 26 April 2021, Pages 830-845
The aim of this study was to evaluate 1-year outcomes of valve–in–mitral annular calcification (ViMAC) in the MITRAL (Mitral Implantation of Transcatheter Valves) trial.
Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings: MITRAL Trial Valve-in-Ring Arm 1-Year Outcomes
MayraGuerreroMDaDee DeeWangMDbAmitPursnaniMDcMichaelSalingerMDdHyde M.RussellMDeMackramEleidMDaTarunChakravartyMDfMarvin H.NgMDbSusheel K.KodaliMDgChristopher U.MeduriMDhAshishPershadMDi?LowellSatlerMDjRonWaksmanMDjIgorPalaciosMDkRichardSmallingMDlMarkReismanMDm†MaryGegenhuberRNnTatianaKaptzanPhDo…William W.O’NeillMDb
doi : 10.1016/j.jcin.2021.01.051
Volume 14, Issue 8, 26 April 2021, Pages 846-858
The authors report 1-year outcomes of high-risk patients with failed surgical annuloplasty rings undergoing transseptal mitral valve–in–ring (MViR) with the SAPIEN 3 aortic transcatheter heart valve (THV).
Prospective Evaluation of Transseptal TMVR for Failed Surgical Bioprostheses: MITRAL Trial Valve-in-Valve Arm 1-Year Outcomes
MayraGuerreroMDaAmitPursnaniMDbAkhilNarangMDcMichaelSalingerMDdDee DeeWangMDeMackramEleidMDaSusheel K.KodaliMDfIsaacGeorgeMDgLowellSatlerMDhRonWaksmanMDhChristopher U.MeduriMDiVivekRajagopalMDiIgnacioInglessisMDjIgorPalaciosMDjMarkReismanMDk?Marvin H.EngMDeHyde M.RussellMDlAshishPershadMDm CharanjitRihalMDa
doi : 10.1016/j.jcin.2021.02.027
Volume 14, Issue 8, 26 April 2021, Pages 859-872
The aim of this study was to assess 1-year clinical outcomes among high-risk patients with failed surgical mitral bioprostheses who underwent transseptal mitral valve-in-valve (MViV) with the SAPIEN 3 aortic transcatheter heart valve (THV) in the MITRAL (Mitral Implantation of Transcatheter Valves) trial.
Transcatheter Mitral Valve Replacement for Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Using Balloon-Expandable Transcatheter Heart Valves?
AlessandroSticchiMDaDavidReinekeMDbFabienPrazMDaStephanWindeckerMDa
doi : 10.1016/j.jcin.2021.02.034
Volume 14, Issue 8, 26 April 2021, Pages 873-878
Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT Trial
RimHalabyMDaHoward C.HerrmannMDaZachary M.GertzMDbScottLimMDcSaibalKarMDdJoAnnLindenfeldMDeWilliam T.AbrahamMDfPaul A.GrayburnMDgSuveekshaNaiduBSaFederico M.AschMDhNeil J.WeissmanMDhYiranZhangMSiMichael J.MackMDgGregg W.StoneMDij
doi : 10.1016/j.jcin.2021.01.049
Volume 14, Issue 8, 26 April 2021, Pages 879-889
The authors sought to evaluate the association between mean mitral valve gradient (MVG) and clinical outcomes among patients who underwent MitraClip treatment for secondary mitral regurgitation (SMR) in the COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation) trial.
The Art of Balancing Functional Mitral Regurgitation Reduction and Gradients After TEER?
Jo?o L.CavalcanteMDPaulSorajjaMD
doi : 10.1016/j.jcin.2021.03.011
Volume 14, Issue 8, 26 April 2021, Pages 890-891
Distal Radial Access: Consensus Report of the First Korea-Europe Transradial Intervention Meeting
Gregory A.SguegliaMD, PhDaBong-KiLeeMD, PhDbByung-RyulChoMDbAvtandilBabunashviliMD, PhDcJin BaeLeeMDdJun-WonLeeMDeKarstenSchenkeMDfSang YeubLeeMD, PhDgStefanHarbMDh
doi : 10.1016/j.jcin.2021.02.033
Volume 14, Issue 8, 26 April 2021, Pages 892-906
Among patients undergoing percutaneous coronary procedures, transradial access, compared with transfemoral access, is associated with a reduced risk for complications including mortality, especially in higher risk patients. However, transradial access is limited by radial artery occlusion (RAO) that despite being mostly asymptomatic because of the extensive anastomoses between the forearm arteries restricts future use of the same radial artery. Distal radial access (DRA) in the anatomic snuffbox or on the dorsum of the hand has recently gained global popularity as an alternative access route for vascular procedures. A strong anatomic and physiological rationale yields potential for significantly reduced risk for RAO and positive impact on procedural outcome for better patient care. Indeed, currently published studies buttress very low rates of RAO after DRA, hence supporting its development. The authors provide an analysis of the foundation of DRA, provide historical background, and offer a critical review of its current status and future directions. Also, given the limited evidence currently available to properly perform DRA in the real world, consensus opinion on what is considered optimal practice is also presented to supplement this document and enhance the implementation of DRA while minimizing its complications.
Characteristics and Outcomes of Patients With History of CABG Undergoing Cardiac Catheterization Via the Radial Versus Femoral Approach
David A.ManlyMDa?WassefKarrowniMDb?Jennifer A.RymerMDcLisa A.KaltenbachMScRajesh V.SwaminathanMDcJohn C.MessengerMDdJ. DawnAbbottMDeArnoldSetoMDfCarmeloPanettaMDgEmmanouilBrilakisMD, PhDhIliasNikolakopoulosMDhIan C.GilchristMDiPrashantKaulMDjHabibDakikMDkSunil V.RaoMDc
doi : 10.1016/j.jcin.2021.01.053
Volume 14, Issue 8, 26 April 2021, Pages 907-916
The aims of this study were to examine rates of radial artery access in post–coronary artery bypass grafting (CABG) patients undergoing diagnostic catherization and/or percutaneous coronary intervention (PCI), whether operators with higher procedural volumes and higher percentage radial use were more likely to perform diagnostic catherization and/or PCI via the radial approach in post-CABG patients, and clinical and procedural outcomes in post-CABG patients who undergo diagnostic catherization and/or PCI via the radial or femoral approach.
“Up in Arms” Making the Argument for Broadening the Use of the Radial Artery?
David L.FischmanMD
doi : 10.1016/j.jcin.2021.02.023
Volume 14, Issue 8, 26 April 2021, Pages 917-918
Transillumination and Tissue-Transparency Photo-Realistic Echocardiography Imaging During Percutaneous Mitral Valve Interventions
ManuelBarreiro-PerezMD, PhDabIgnacioCruz-Gonz?lezMD, PhDabcJavierMartin-MoreirasMD, PhDabcElenaDiaz-PelaezMDabJean CarlosNu?ezMDabPabloLuengo-MondéjarMDabPedro L.S?nchezMD, PhDabc
doi : 10.1016/j.jcin.2021.01.034
Volume 14, Issue 8, 26 April 2021, Pages 919-922
Radial Aneurysmal AV Fistula as a Complication of Coronary Angioplasty
Jean-JacquesGoyMDFrancineTinguelyMDJean-BaptisteZerlauthMDGregoryKhatchatourovMD
doi : 10.1016/j.jcin.2021.02.011
Volume 14, Issue 8, 26 April 2021, Pages 923-924
Massive Primary Mitral Regurgitation Due to Chordae Rupture: Treatment With New-Generation Edge-to-Edge Repair Devices
Jean PaulVilchez-TschischkeMD, PhDaIsaacPascualMD, PhDbAnaOsa-SaezMD, PhDaCarmenDe la Fuente MoralesMDcAzucenaPajares MonchoMDcJose LuisDiez-GilMD, PhDa
doi : 10.1016/j.jcin.2020.12.026
Volume 14, Issue 8, 26 April 2021, Pages e77-e79
Coronary Embolism Due to Radial Artery Tearing
SamuelLarue-GrondinMDaFabriceIeroncigMDbPhilippeGarotMDaHakimBenamerMDa
doi : 10.1016/j.jcin.2021.01.050
Volume 14, Issue 8, 26 April 2021, Pages e81-e82
Complex PCI Techniques in Rescue of a Rare Complication of Coronary Angiography
Thomas E.KaierMD, MBA, PhDaJonathanBennettMBBS, MScbAntonis N.PavlidisMD, PhDab
doi : 10.1016/j.jcin.2021.02.006
Volume 14, Issue 8, 26 April 2021, Pages e83-e85
Alternative Hypothesis for the Discrepancy in Peridevice Leak Detection
SimonLindnerMDMichaelBehnesMDIbrahimAkinMD
doi : 10.1016/j.jcin.2021.02.016
Volume 14, Issue 8, 26 April 2021, Page 925
Reply: Alternative Hypothesis for the Discrepancy in Peridevice Leak Detection
KasperKorsholmMD, PhDJesper M?llerJensenMD, PhDBjarne LindeN?rgaardMD, PhDJacquelineSawMDJens ErikNielsen-KudskMD, DMSc
doi : 10.1016/j.jcin.2021.02.043
Volume 14, Issue 8, 26 April 2021, Pages 925-926
Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement
MatthiasRaschpichlerMDSuzannede Waha-ThieleMDMohamedAbdel-WahabMDHolgerThieleMDDavidHolzheyMDMichaelBorgerMD, PhD
doi : 10.1016/j.jcin.2021.02.018
Volume 14, Issue 8, 26 April 2021, Pages 926-927
Reply: Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement
Michel Pompeu B.O.S?MD, MSc, PhDJefVan den EyndeBScMatheusSimonatoMDPhilippePibarotDMV, PhDMarie-AnnickClavelDVM, PhDcoauthors
doi : 10.1016/j.jcin.2021.02.024
Volume 14, Issue 8, 26 April 2021, Pages 927-928
What Is the Real IMPACT of an Acronym?
Jean-LouisGayetMD
doi : 10.1016/j.jcin.2021.03.020
Volume 14, Issue 8, 26 April 2021, Pages 928-929
Antiplatelet Therapy After Stenting at the Crossroads: Easiest or Personalized Therapy?
I?igoLozanoMD, PhDJose R.RumorosoMD, PhDArmandoPerez de PradoMD, PhDRaulMorenoMD, PhDFelipeHernandezMD, PhD
doi : 10.1016/j.jcin.2021.03.019
Volume 14, Issue 8, 26 April 2021, Pages 929-930
Sex Differences in the Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy
JayakumarSreenivasanMD, MScMuhammad ShahzebKhanMD, MScRisheekKaulMDDhrubajyotiBandyopadhyayMDUrvashiHoodaMDWilbert S.AronowMDHoward A.CooperMDJulio A.PanzaMDSrihari S.NaiduMD, MSc
doi : 10.1016/j.jcin.2020.10.002
Volume 14, Issue 8, 26 April 2021, Pages 930-932
Tableside Skirt Modification of the SAPIEN 3 Valve to Reduce Paravalvular Leak During Transcatheter Mitral Valve Replacement
Adam B.GreenbaumMDEmilyPerdoncinMDGaetanoPaoneMDKendra J.GrubbMDJoe X.XieMDPatrick T.GleasonMDRobert J.LedermanMDVasilis C.BabaliarosMD
doi : 10.1016/j.jcin.2021.01.016
Volume 14, Issue 8, 26 April 2021, Pages 932-934
Patient-Specific Neocommissural Alignment of the Evolut Valve: A Pilot Study in Transcatheter Aortic Valve-in-Valve Replacement
MitsunobuKitamuraMDJohannesWildeMDOliverDumpiesMDMatthiasGutberletMDRobinGohmannMDMasafumiShibataMDThiloNoackMDHolgerThieleMDDavidHolzheyMDMohamedAbdel-WahabMD
doi : 10.1016/j.jcin.2020.12.002
Volume 14, Issue 8, 26 April 2021, Pages 934-936
